/Viatris%20Inc%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
With a market cap of $10.2 billion, Viatris Inc. (VTRS) operates as a healthcare company in North America and internationally. Founded in 1961, the Canonsburg, Pennsylvania-based company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets.
Shares of the drug manufacturer have underperformed the broader market over the past year. VTRS stock has tanked 28.3% over the past 52 weeks and 31.9% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 8.2% over the past year but has dropped 4.7% in 2025.